Rankings
▼
Calendar
KYMR FY 2018 Earnings — Kymera Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
KYMR
Kymera Therapeutics, Inc.
$7B
FY 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$205,000
Operating Income
-$21M
Net Income
-$21M
EPS (Diluted)
$-0.48
Cash Flow
Operating Cash Flow
-$18M
Free Cash Flow
-$19M
Stock-Based Comp.
$648,000
Balance Sheet
Total Assets
$44M
Total Liabilities
$79M
Stockholders' Equity
-$34M
Cash & Equivalents
$41M
← Q3 2019
All Quarters